**Dear editor**

We took great interest in the recent article by Thomsen et al[@b1-clep-11-125] outlining factors which predicted adherence to follow-up diagnostic colonoscopy in the Danish Colorectal Screening Program. This is particularly relevant as colorectal cancer (CRC) is the second most common cause of cancer mortality worldwide.[@b2-clep-11-125] Evaluating factors which affect screening uptake and follow-up are pivotal to public health as early detection of cancer results in dramatically improved survival.[@b3-clep-11-125]

In this study, Thomsen et al[@b1-clep-11-125] assessed comorbidity using the Charlson Comorbidity Index (CCI) score, single diagnoses, the number of in-hospital stays within the past year and looked at adherence following a positive fecal occult blood test (FOBT). The original article is detailed and provides a wealth of information aiding understanding of factors which may affect uptake of diagnostic colonoscopy. The CCI score that Thomsen et al[@b1-clep-11-125] used evaluated mainly physical comorbidities including myocardial infarction, congestive heart failure, peripheral vascular disease and cerebrovascular disease. We applaud the authors for identifying factors that affect adherence to diagnostic colonoscopy and we agree that severe comorbidity may affect uptake of colonoscopy following a positive FOBT.

There were, however, a number of important conditions, such as psychiatric comorbidities, which were not explored by this study. In a previous study by Kodl et al,[@b4-clep-11-125] the authors found that veterans with mental health diagnoses were significantly less likely to be screened for CRC than individuals with no mental health diagnoses. Similarly, another study found that those with a lower self-perceived mental health status had a reduced FOBT uptake for CRC screening,[@b5-clep-11-125] recognizing that individuals with poor mental health require additional support and follow-up from screening services.

In the current study by Thomsen et al,[@b1-clep-11-125] 38.4% of individuals did not want any further follow-up tests. We believe it is imperative that future studies evaluate participants' mental health status and preexisting psychiatric comorbidities to determine whether this is an attributing factor for not taking up colonoscopy. We, therefore, recommend that future studies should specifically outline psychiatric conditions and the number of diagnoses, incorporating this into the initial comorbidity score. Although it can be argued that poor mental health is a confounding variable, and will inevitably be present in those with chronic health conditions, we believe this further reinforces the need to determine the effect of psychiatric factors on nonadherence to follow-up measures.

A huge barrier to accurate and prompt diagnosis in those with psychiatric comorbidities is differential access to opportunities for screening. This is likely due to a lack of integration between social health services and screening services. Attempting to determine the influence of psychiatric comorbidities is a difficult task, but one which we believe is essential to tackle inequalities and subsequently deliver effective health care to individuals with mental health conditions. We, therefore, hope that future studies will attempt to define psychiatric factors influencing uptake of follow-up diagnostic measures.
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